Treatment of STAT3 Deficient Hyper IgE Syndrome with Monoclonal Antibodies Targeting Allergic Inflammation
The Journal of Allergy and Clinical Immunology: In Practice(2022)
摘要
Single transducer and activator of transcription 3 (STAT3) dominant negative (DN) is a primary immunodeficiency (PID) manifested by oto-sinopulmonary and skin bacterial infections; eczematoid dermatitis; mucocutaneous candidiasis; elevated serum immunoglobulin E (IgE); and skeletal, vascular, and connective tissue abnormalities. In recent years, monoclonal antibodies have emerged to manage atopic dermatitis (AD) and eosinophilic disease raising interest in whether STAT3 DN patients could have clinical benefit.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要